Literature DB >> 9665458

The long and short of chromosome 11 in breast cancer.

I F Newsham1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9665458      PMCID： PMC1852943          DOI： 10.1016/S0002-9440(10)65538-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  39 in total

1.  Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years.

Authors:  P P Rosen; C Kosloff; P H Lieberman; F Adair; D W Braun
Journal:  Am J Surg Pathol       Date:  1978-09       Impact factor: 6.394

2.  Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping.

Authors:  H J Scrable; D P Witte; B C Lampkin; W K Cavenee
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

3.  Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.

Authors:  R F Chuaqui; Z Zhuang; M R Emmert-Buck; L A Liotta; M J Merino
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

4.  Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.

Authors:  H Fujii; R Szumel; C Marsh; W Zhou; E Gabrielson
Journal:  Cancer Res       Date:  1996-11-15       Impact factor: 12.701

5.  Loss of heterozygosity in normal tissue adjacent to breast carcinomas.

Authors:  G Deng; Y Lu; G Zlotnikov; A D Thor; H S Smith
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

6.  Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24.

Authors:  G M Hampton; L A Penny; R N Baergen; A Larson; C Brewer; S Liao; R M Busby-Earle; A W Williams; C M Steel; C C Bird
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

7.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.

Authors:  M Negrini; D Rasio; G M Hampton; S Sabbioni; S Rattan; S L Carter; A L Rosenberg; G F Schwartz; Y Shiloh; W K Cavenee
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

8.  Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

Authors:  J Mackay; P A Elder; D J Porteous; C M Steel; R A Hawkins; J J Going; U Chetty
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

9.  Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.

Authors:  A Viel; F Giannini; L Tumiotto; F Sopracordevole; M C Visentin; M Boiocchi
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

10.  Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Authors:  W D Foulkes; I G Campbell; G W Stamp; J Trowsdale
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640
View more
  9 in total

Review 1.  Significance of lobular intraepithelial neoplasia at margins of breast conservation specimens: a report of 38 cases and literature review.

Authors:  Sophia K Apple; Mahan Matin; Eric P Olsen; Neda A Moatamed
Journal:  Diagn Pathol       Date:  2010-08-20       Impact factor: 2.644

2.  Phospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancer.

Authors:  Ling Mei; Qian Hu; Jing Peng; Jiaying Ruan; Juan Zou; Qin Huang; Shanling Liu; He Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.

Authors:  Min Yi; Funda Meric-Bernstam; Lavinia P Middleton; Banu K Arun; Isabelle Bedrosian; Gildy V Babiera; Rosa F Hwang; Henry M Kuerer; Wei Yang; Kelly K Hunt
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

4.  miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.

Authors:  Brian D Adams; Vikram B Wali; Christopher J Cheng; Sachi Inukai; Carmen J Booth; Seema Agarwal; David L Rimm; Balázs Győrffy; Libero Santarpia; Lajos Pusztai; W Mark Saltzman; Frank J Slack
Journal:  Cancer Res       Date:  2015-12-16       Impact factor: 12.701

5.  miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention.

Authors:  Niloo Srivastava; Siddharth Manvati; Archita Srivastava; Ranjana Pal; Ponnusamy Kalaiarasan; Shilpi Chattopadhyay; Sailesh Gochhait; Raina Dua; Rameshwar N K Bamezai
Journal:  Breast Cancer Res       Date:  2011-04-04       Impact factor: 6.466

6.  Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression.

Authors:  K Kittiniyom; K M Gorse; F Dalbegue; J H Lichy; J K Taubenberger; I F Newsham
Journal:  Breast Cancer Res       Date:  2001-02-12       Impact factor: 6.466

7.  The role of microsatellite instability at chromosome 11p15.5 in the progression of breast ductal carcinoma.

Authors:  Dong-Ja Kim; Ji-Young Park; Myung-Hoon Lee; Yoon-Kyung Sohn
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

8.  Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.

Authors:  Alison K Ward; Paul Mellor; Shari E Smith; Stephanie Kendall; Natasha A Just; Frederick S Vizeacoumar; Sabuj Sarker; Zoe Phillips; Riaz Alvi; Anurag Saxena; Franco J Vizeacoumar; Svein A Carlsen; Deborah H Anderson
Journal:  Breast Cancer Res       Date:  2016-01-25       Impact factor: 6.466

9.  Association Analysis of Methylenetetrahydrofolate Reductase Common Gene Polymorphisms with Breast Cancer Risk in an Iranian Population: A Case-Control Study and a Stratified Analysis.

Authors:  Mohammad Karimian; Nasrin Rezazadeh; Tahereh Khamehchian
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.